Patricio Massera Joins VIVEbiotech as President to Lead Global Expansion
Company - People | Jul 03, 2025 | Ampersand Capital Partners
VIVEbiotech, a Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral vector development for gene and cell therapies, has announced the appointment of Patricio Massera as President. This significant leadership appointment is backed by a recent investment from Ampersand Capital Partners, a healthcare-focused private equity firm. With over 25 years of experience, Massera is tasked with guiding VIVEbiotech's global expansion and enhancing operational quality. The company aims to scale its capabilities and strengthen strategic partnerships as it continues to cater to established global pharmaceutical leaders and innovative start-ups. VIVEbiotech, recognized for its expertise in both ex vivo and in vivo applications, serves a diverse customer base across Europe, the U.S., and Australia. The board, led by Chairperson Dr. Stefan Beyer, expressed confidence in Massera's ability to drive growth while maintaining standards of excellence.
Sectors
- Biopharmaceuticals
- Private Equity
Geography
- Spain – VIVEbiotech is headquartered in San Sebastian, Gipuzkoa, Spain, which is a focal point of its operations.
- United States – Ampersand Capital Partners has offices in Boston, signifying its geographical relevance to the article.
Industry
- Biopharmaceuticals – VIVEbiotech operates in the biopharmaceutical sector as it specializes in the manufacturing of lentiviral vectors used in gene and cell therapies.
- Private Equity – Ampersand Capital Partners is a private equity firm investing in VIVEbiotech to aid its growth strategy, reflecting the private equity sector's involvement.
Financials
- $3 billion – The assets under management by Ampersand Capital Partners.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| VIVEbiotech | Target | Company | A CDMO specializing in lentiviral vectors for gene and cell therapy. |
| Ampersand Capital Partners | Investor | Company | A private equity firm focused on healthcare sector investments. |
| Patricio Massera | New President | Person | Appointed as President of VIVEbiotech, bringing over 25 years of CDMO sector experience. |
| Dr. Stefan Beyer | Chairperson | Person | Chairperson of VIVEbiotech and veteran CDMO executive. |
| Jon Alberdi | CEO | Person | CEO of VIVEbiotech, leading its global leadership in lentiviral vector manufacturing. |